Replies to post #90687 on $heff's $tation of $tocks & $olid DD

[BiotechValues]

$XXII + 10% on volume

The cigarettes used in the study published by the New England Journal of Medicine referenced in this video and paid for by the FDA are from XXII:

http://www.nejm.org/action/showMediaPlayer?doi=10.1056/NEJMsa1502403&aid=NEJMsa1502403_attach_1

XXII could be the FIRST and ONLY tobacco company to have FDA approval to advertise their cigarettes as a smoking cessation aid.

FDA application pending: http://finance.yahoo.com/news/22nd-century-announces-strategic-hire-125900089.html


XXII "is committed to working collaboratively with the FDA to demonstrate that our Very Low Nicotine cigarettes and our Low Tar-to-Nicotine Ratio cigarettes are legitimate – and enormously important – modified risk tobacco products.”

So- how much might Philip Morris or Reynolds Tobacco pay for XXII which is heavily patented in plant genetics....? Especially after FDA has pulled some of their "modified risk" products from the shelves?

http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm462407.htm

many many many times current market cap.

[BiotechValues]

$XXII FDA moving FAST on the Modified Risk Tobacco application

http://finance.yahoo.com/news/22nd-century-meets-fda-historic-152700215.html …


Also- Jason Naopdono weighs in...

http://www.bionapcfa.com/2016/01/22nd-century-group-filed-modified-risk.html